Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Urothelial Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00942331
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Who this might be right for
Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Prostate Carcinoma+10 more
National Cancer Institute (NCI) 506
Testing effectiveness (Phase 2)Looking for participantsNCT07506057
What this trial is testing

Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy

Who this might be right for
Urothelial CarcinomaBiliary Tract CancerHER2
Xiujuan Qu 20
Testing effectiveness (Phase 2)UnknownNCT04486781
What this trial is testing

Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Large-scale testing (Phase 3)Study completedNCT02426125
What this trial is testing

Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Eli Lilly and Company 530
Testing effectiveness (Phase 2)UnknownNCT05775874
What this trial is testing

Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Who this might be right for
Urothelial Carcinoma
Abbisko Therapeutics Co, Ltd 80
Testing effectiveness (Phase 2)Ended earlyNCT03288545
What this trial is testing

Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Global Development, Inc. 348
Not applicableStudy completedNCT05431777
What this trial is testing

Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

Who this might be right for
Urothelial Carcinoma
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 79
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Early research (Phase 1)Active Not RecruitingNCT04963153
What this trial is testing

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+17 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02351739
What this trial is testing

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer

Who this might be right for
Metastatic Urothelial Carcinoma
Acerta Pharma BV 78
Very early researchStudy completedNCT03473730
What this trial is testing

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Who this might be right for
Bladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT07221942
What this trial is testing

Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial CarcinomaUnresectable Urothelial CarcinomaAdvanced Urothelial Carcinoma
Fox Chase Cancer Center 97
Testing effectiveness (Phase 2)Study completedNCT02665039
What this trial is testing

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 62
Large-scale testing (Phase 3)Looking for participantsNCT07393542
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 453
Not applicableLooking for participantsNCT06967961
What this trial is testing

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Who this might be right for
Urothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more
Institut Claudius Regaud 450
Early research (Phase 1)Ended earlyNCT03265080
What this trial is testing

ADXS-NEO Expressing Personalized Tumor Antigens

Who this might be right for
Colon Cancer MetastaticHead and Neck Cancer MetastaticMetastatic Non-Small Cell Lung Cancer+2 more
Advaxis, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT03029832
What this trial is testing

MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy

Who this might be right for
Urothelial Carcinoma
Genentech, Inc. 5
Testing effectiveness (Phase 2)Looking for participantsNCT05296564
What this trial is testing

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Who this might be right for
Sarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more
Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Ended earlyNCT03389438
What this trial is testing

Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasm
Beijing Huanxing Cancer Hospital 6
Next Page